GLP-1 receptor agonists like Wegovy (semaglutide) and Zepbound (tirzepatide) reduce food noise by acting directly on the brain regions responsible for reward-driven food thinking, not just on the stomach or appetite signals in the gut
The goal is that, by the time you stop taking GLP-1s, not only will you have lost weight and improved your metabolic system significantlyyou will also have the tools to maintain the food, exercise, sleep, and emotional health habits needed to sustain those changes over time
No multi-year human safety data exists for the No DAC version specifically
Hives are possible and usually signal an allergic response
Strive notes specifically that "dosing may deviate from this pattern to accommodate patient-specific needs." This is not just a disclaimer
"This market has grown so large and diffuse that it's difficult for regulators to oversee every pharmacy supplying these medications," he said